A critical discovery in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This vital cancer protector protein is frequently inactivated in many kinds of cancer, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research